Policy Documents
- 2005-Enzi
- testimony-nord
- testimony-campbell
- orphan-research.pdf
- statement-dorman
- statement-dorman
- 2005-wiley
- 2005-meyers
- senate-help
- workshop-ultra-rare
- roscoe-tribute
- special-emphasis-panel
- orphan-dev-conf
- patient-perspective
- collaboration-pharma
- history-orphan-drug-act
- orgs-orphan-drug-act
- testimony-2003-dorman
- pdufa-2001
- stem-cell
- fda-modernization
- generics-conf
- gene-therapy
- ssa-commissioner
- priority-orphans
- nih-research
- gene-patenting
- insurance-drugs
- genetic-discrimination
- patients-rights
- patient-trials
- AAPDAmicusBrief.pdf
- dorman-7-10
- dorman-6-10
- dorman-7-10
- fda-6-10
- mdufa-ppt
- FDA5312011.pdf
- cms-tiers-2011
- 2011 NIH Dear Colleague
- fda-pdac-2011
- medicare-cuts-2011
- pcori-7-2011
- citizen-petition
- health-funding-2011
- alliance-9-2011
- shuren-risk
- mullin-risk
- cdrh-risk-2011
- nord-study-fda-approval
- nih-2012-funding
- maprx-2011
- help-2011
- NIHFY2012HouseSignonLetterDraft.pdf
- copy_of_MAPRxSuperCommitteeLetter10.12.11.pdf
- HELP COI Letter_Senate_Final.pdf
- testimony-10-24-2011
- Letter to OHRP
- ohrp-2011-nwe
- Ultra Orphan Act
- NORD Ultra Response
- pdufa12012.pdf
- crec-2012
- compassionate-allowances-101
- aplus-2012
- ssa-teleconference-2012
- Fast Act
- Policy Statement Fast-Treat Acts
- HDE Reforms
- HDE Pag Letter 2012
- Pediatric Device Letter
- Final Pediatric Device Letter
- Harkin Enzi 2012
- bpca-prea-2012
- hde-pag-letter
- ehb-letter-2012
- Letter to House Officials 5-2012
- bass-2012-statement
- fda-peripheral-may-2012
- fda-risk-summary
- webinar-7-2012
- webinar-7-2012-audio
- ACA SCOTUS 2012
- pediatric-rogers
- pediatric-brown
- Zallen Letter
- Sequestration Letter
- lhhs-2012-signon
- clia-letter-2012
- patient-focused-comments-2012
- CLIA-2012-signatures
- Dec 6 Saltonstall SSA
- medical-device-consortium
- NORD PCORI 2012
- MAPRx-2012
- MAPRx-congress-2012
- saltonstall-2013-oda
- newborn-screening
- testimony-dorman-2013
- AHRQ Letter 2013
